InsiderClue
Insiders · Profile

GSK plc

10% owner at Wave Life Sciences · 10% owner at CVRx · 10% owner at Innoviva · and 7 more. Filing since 17 Mar 2009. CIK 0001131399

WVE Wave Life Sciences, Inc. 10% owner · 3 trades CVRX CVRx, Inc. 10% owner · 1 trade INVA Innoviva, Inc. 10% owner · 21 trades BCYC BICYCLE THERAPEUTICS PLC 10% owner · 3 trades NKTX Nkarta, Inc. Director · 1 trade PGNY Progyny, Inc. 10% owner · 1 trade SPRO Spero Therapeutics, Inc. 10% owner · 2 trades CRSP CRISPR Therapeutics AG 10% owner · 1 trade TBPH Theravance Biopharma, Inc. 10% owner · 2 trades DGX Quest Diagnostics Director · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
WVE Wave Life Sciences, Inc.
11 Dec 2025
10% owner
Bought
1,470,000
$27.93M
8.8%
WVE Wave Life Sciences, Inc.
27 Sep 2024
10% owner
Bought
2,791,930
$22.34M
20.0%
WVE Wave Life Sciences, Inc.
7 Dec 2023
10% owner
Bought
3,300,000
$16.50M
30.9%
CVRX CVRx, Inc.
2 Jul 2021
10% owner
Bought
275,000
$4.95M
37.5%
INVA Innoviva, Inc.
20 May 2021
10% owner
Sold, plan not stated
32,005,260
$392.06M
100%
BCYC BICYCLE THERAPEUTICS PLC
15 Jul 2020
10% owner
Sold, plan not stated
3,147
$61.05K
0.2%
NKTX Nkarta, Inc.
14 Jul 2020
Director
Bought
833,333
$15.00M
36.0%
BCYC BICYCLE THERAPEUTICS PLC
14 Jul 2020
10% owner
Sold, plan not stated
1,597
$30.78K
0.1%
PGNY Progyny, Inc.
20 May 2020
10% owner
Sold, plan not stated
4,000,000
$103.00M
39.1%
BCYC BICYCLE THERAPEUTICS PLC
28 May 2019
Director
Bought
385,714
$5.40M
25.2%
SPRO Spero Therapeutics, Inc.
17 Jul 2018
10% owner
Bought
80,000
$1.00M
4.3%
SPRO Spero Therapeutics, Inc.
6 Nov 2017
10% owner
Bought
428,571
$6.00M
30.1%
CRSP CRISPR Therapeutics AG
24 Oct 2016
10% owner
Bought
66,500
$931.00K
2.1%
TBPH Theravance Biopharma, Inc.
14 Mar 2016
10% owner
Bought
1,301,015
$29.96T
15.6%
TBPH Theravance Biopharma, Inc.
7 Oct 2015
10% owner
Bought
44,574
$27.08B
0.5%
INVA Innoviva, Inc.
7 Aug 2015
10% owner
Bought
245,828
$856.92B
0.8%
INVA Innoviva, Inc.
11 May 2015
10% owner
Bought
85,579
$117.18B
0.3%
INVA Innoviva, Inc.
2 Mar 2015
10% owner
Bought
92,674
$155.11B
0.3%
INVA Innoviva, Inc.
4 Nov 2014
10% owner
Bought
832,456
$10.64T
2.7%
INVA Innoviva, Inc.
11 Aug 2014
10% owner
Bought
172,651
$675.46B
0.6%
INVA Innoviva, Inc.
9 May 2014
10% owner
Bought
317,770
$2.72T
1.1%
INVA Innoviva, Inc.
11 Feb 2014
10% owner
Bought
342,229
$4.40T
1.1%
INVA Innoviva, Inc.
29 Oct 2013
10% owner
Bought
130,473
$641.09B
0.4%
INVA Innoviva, Inc.
30 Jul 2013
10% owner
Bought
3,064,407
$342.76T
11.5%
INVA Innoviva, Inc.
30 Apr 2013
10% owner
Bought
193,563
$1.30T
0.7%
INVA Innoviva, Inc.
15 Feb 2013
10% owner
Bought
116,527
$299.14B
0.4%
INVA Innoviva, Inc.
2 Nov 2012
10% owner
Bought
280,348
$1.76T
1.1%
INVA Innoviva, Inc.
3 Aug 2012
10% owner
Bought
316,334
$8.92M
1.2%
INVA Innoviva, Inc.
16 May 2012
10% owner
Bought
10,000,000
$212.89M
63.2%
INVA Innoviva, Inc.
14 Feb 2012
10% owner
Bought
88,468
$1.60M
0.6%
INVA Innoviva, Inc.
1 Nov 2011
10% owner
Bought
58,411
$1.30M
0.4%
INVA Innoviva, Inc.
2 Aug 2011
10% owner
Bought
102,466
$2.02M
0.7%
INVA Innoviva, Inc.
3 May 2011
10% owner
Bought
261,299
$6.69M
4.4%
INVA Innoviva, Inc.
18 Feb 2011
10% owner
Bought
152,278
$3.61M
2.6%
DGX Quest Diagnostics
31 Jan 2011
Director
Sold, plan not stated
30,755,151
$1.69B
100%
INVA Innoviva, Inc.
29 Nov 2010
10% owner
Bought
5,750,000
$129.38M
opened
DGX Quest Diagnostics
19 Mar 2009
Director
Sold, plan not stated
4,749,157
$210.54M
13.4%
DGX Quest Diagnostics
18 Mar 2009
Director
Sold, plan not stated
500,000
$22.85M
1.4%
DGX Quest Diagnostics
17 Mar 2009
Director
Sold, plan not stated
500,000
$22.75M
1.4%
39 decisions on file.